Vassilev A, Ozer Z, Navara C, Mahajan S, Uckun F M
Parker Hughes Cancer Center, Molecular Signal Transduction Laboratory, Departments of Immunology, Molecular Biology, and Biochemistry, Hughes Institute, St. Paul, Minnesota 55113, USA.
J Biol Chem. 1999 Jan 15;274(3):1646-56. doi: 10.1074/jbc.274.3.1646.
Bruton's tyrosine kinase (BTK) is a member of the Src-related Tec family of protein tyrosine kinases. Mutations in the btk gene have been linked to severe developmental blocks in human B-cell ontogeny leading to X-linked agammaglobulinemia. Here, we provide unique biochemical and genetic evidence that BTK is an inhibitor of the Fas/APO-1 death-inducing signaling complex in B-lineage lymphoid cells. The Src homology 2, pleckstrin homology (PH), and kinase domains of BTK are all individually important and apparently indispensable, but not sufficient, for its function as a negative regulator of Fas-mediated apoptosis. BTK associates with Fas via its kinase and PH domains and prevents the FAS-FADD interaction, which is essential for the recruitment and activation of FLICE by Fas during the apoptotic signal. Fas-resistant DT-40 lymphoma B-cells rendered BTK-deficient through targeted disruption of the btk gene by homologous recombination knockout underwent apoptosis after Fas ligation, but wild-type DT-40 cells or BTK-deficient DT-40 cells reconstituted with wild-type human btk gene did not. Introduction of an Src homology 2 domain, a PH domain, or a kinase domain mutant human btk gene into BTK-deficient cells did not restore the resistance to Fas-mediated apoptosis. Introduction of wild-type BTK protein by electroporation rendered BTK-deficient DT-40 cells resistant to the apoptotic effects of Fas ligation. BTK-deficient RAMOS-1 human Burkitt's leukemia cells underwent apoptosis after Fas ligation, whereas BTK-positive NALM-6-UM1 human B-cell precursor leukemia cells expressing similar levels of Fas did not. Treatment of the anti-Fas-resistant NALM-6-UM1 cells with the leflunomide metabolite analog alpha-cyano-beta-methyl-beta-hydroxy-N-(2, 5-dibromophenyl)propenamide, a potent inhibitor of BTK, abrogated the BTK-Fas association without affecting the expression levels of BTK or Fas and rendered them sensitive to Fas-mediated apoptosis. The ability of BTK to inhibit the pro-apoptotic effects of Fas ligation prompts the hypothesis that apoptosis of developing B-cell precursors during normal B-cell ontogeny may be reciprocally regulated by Fas and BTK.
布鲁顿酪氨酸激酶(BTK)是与Src相关的Tec家族蛋白酪氨酸激酶的成员之一。btk基因突变与人类B细胞个体发育过程中的严重发育阻滞有关,可导致X连锁无丙种球蛋白血症。在此,我们提供了独特的生化和遗传学证据,表明BTK是B系淋巴细胞中Fas/APO-1死亡诱导信号复合物的抑制剂。BTK的Src同源2结构域、普列克底物蛋白同源(PH)结构域和激酶结构域对于其作为Fas介导的细胞凋亡负调节因子的功能均各自具有重要意义,且显然不可或缺,但并不充分。BTK通过其激酶结构域和PH结构域与Fas结合,并阻止FAS-FADD相互作用,而这种相互作用对于凋亡信号期间Fas招募和激活FLICE至关重要。通过同源重组敲除btk基因而使BTK缺陷的Fas抗性DT-40淋巴瘤B细胞在Fas连接后发生凋亡,但野生型DT-40细胞或用野生型人btk基因重建的BTK缺陷DT-40细胞则不会。将Src同源2结构域、PH结构域或激酶结构域突变的人btk基因导入BTK缺陷细胞并不能恢复对Fas介导的细胞凋亡的抗性。通过电穿孔导入野生型BTK蛋白可使BTK缺陷的DT-40细胞对Fas连接的凋亡效应产生抗性。BTK缺陷的RAMOS-1人伯基特白血病细胞在Fas连接后发生凋亡,而表达相似水平Fas的BTK阳性NALM-6-UM1人B细胞前体白血病细胞则不会。用来氟米特代谢物类似物α-氰基-β-甲基-β-羟基-N-(2,5-二溴苯基)丙烯酰胺(一种有效的BTK抑制剂)处理抗Fas的NALM-6-UM1细胞,可消除BTK与Fas的结合,而不影响BTK或Fas的表达水平,并使其对Fas介导的细胞凋亡敏感。BTK抑制Fas连接的促凋亡效应的能力提示了这样一种假说,即在正常B细胞个体发育过程中,发育中的B细胞前体的凋亡可能受到Fas和BTK的相互调节。